Skip to main content
. 2016 Mar;7(2):49–59. doi: 10.4103/0976-0105.177706

Table 5.

Hematological and biochemical parameters in deferasirox-treated pediatric patients with beta thalassemia major or sickle cell anemia

graphic file with name JBCP-7-49-g005.jpg